MED logo

Medifast (MED) Company Overview

Profile

Full Name:

Medifast, Inc.

Sector:

Consumer Cyclical

Industry:

Personal Services

Country:

United States

IPO:

December 30, 1993

Indexes:

Not included

Website:

http://medifastinc.com

Description:

Medifast, Inc. is an American company that specializes in the development, production, and sales of special nutrition and weight control programs, as well as products for a healthy lifestyle. The company is based in Baltimore, Maryland and was founded in 1980. Medifast, Inc.'s products and programs are developed in collaboration with scientists and doctors specifically for clients to help them achieve optimal weight and get into a healthy shape. The company's products focus on developing the right dietary plan for each client, motivation and workout programs, and instilling healthy habits.

Key Details

Price

$14.47

Market Cap

$158.27 M(Small cap)

Last Dividend

$1.65

TTM Dividend Yield

-

Annual Revenue

$602.46 M(-43.80% YoY)

Annual EPS

$0.19(-97.91% YoY)

PE Ratio

80.39

Annual ROE

1.02%

Annual Debt To Equity

0.00

Beta

0.45

Events Calendar

Earnings

Next earnings date:

Apr 29, 2025

Recent quarterly earnings:

Feb 18, 2025

Recent annual earnings:

Feb 18, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Sep 18, 2023
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 19, 25 DA Davidson
Neutral
Nov 5, 24 DA Davidson
Neutral
Jul 22, 24 DA Davidson
Underperform
Jun 5, 24 DA Davidson
Underperform
Apr 30, 24 DA Davidson
Neutral
Feb 21, 24 DA Davidson
Neutral
Oct 13, 23 Stephens & Co.
Equal-Weight
Aug 8, 23 DA Davidson
Neutral
Jul 31, 23 DA Davidson
Neutral
May 2, 23 DA Davidson
Neutral

Screeners with MED included

Growing Shares Outstanding
US stocks
High Piotroski score stocks
Stocks below SMA 200
Stocks recommended to hold
Stocks below analysts price target
All stocks
High Altman Z score stocks
Consumer cyclical sector
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$14.47
MED price is $14.47

Price All-time High

$332.25
MED price is currently -95.64% below its historical high of $332.25

Price Analysts Target

$15.75
MED price is currently -8.13% lower than the consensus analysts' forecast

Price Today Change

-1.36%
MED price is down -1.36% today

Price YTD Change

-17.17%
MED price is down -17.17% since January 1st

Price 3-Year Change

-91.87%
MED price is down -91.87% over the past 3 years

Market cap

Market Cap

$158.27 M
MED market capitalization is $158.27 million

Market Cap 3-Year Change

-92.3%
MED market capitalization is down -92.3% over the past 3 years

Market Cap All-time High

$3.91 B
MED market capitalization is currently -95.95% below its historical high of $3.91 billion

Market Cap Sector Rank

30.91%
MED market capitalization is higher than 30.91% of companies in Consumer Cyclical sector

Technical

Beta

0.45
MED beta is 0.45

200-day SMA

$19.03
MED price is currently -23.97% below its 200-day simple moving average

14-day RSI

37.02
MED 14-day relative strength index is 37.02

30-day Relative Volume

1.16
MED 30-day relative volume is 1.16

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.65
MED last dividend was $1.65 per share, with an ex-dividend date of September 18, 2023

Next Dividend

-
MED next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

-
MED annual dividend per share value is unknown

Annual Dividend Per Share Sector Rank

-
MED annual dividend per share is unknown

Annual Dividend Per Share 1-Year Change

-
MED annual dividend per share 1-year change is unknown

Annual Dividend Per Share 3-Year Change

-
MED annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

-
MED annual dividend yield value is unknown

Annual Dividend Yield Sector Rank

-
MED annual dividend yield is unknown

Other

Annual Payout Ratio

34.19%
MED annual payout ratio is 34.19%

Annual Dividends Paid

$715.00 K
MED annual dividends paid is $715.00 thousand

Annual FCF

$17.02 M
MED annual free cash flow is $17.02 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$602.46 M
MED annual revenue is $602.46 million

Annual Revenue Analysts Estimate

$442.35 M
MED annual revenue is currently +36.20% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

-43.8%
MED annual revenue is down -43.8% year-on-year

Annual Revenue Sector Rank

39.7%
MED annual revenue is higher than 39.7% of companies in Consumer Cyclical sector

Profit

Annual Gross Profit

$444.62 M
MED annual gross profit is $444.62 million

Annual Gross Margin

73.80%
MED annual gross profit margin is 73.80%

Annual Operating Profit

$2.88 M
MED annual operating income is $2.88 million

Annual Operating Margin

0.48%
MED annual operating profit margin is 0.48%

Annual Net Income

$2.09 M
MED annual net profit is $2.09 million

Annual Net Margin

0.35%
MED annual net profit margin is 0.35%

EPS

Annual EPS

$0.19
MED annual earnings per share is $0.19

Annual EPS Analysts Estimate

-$0.43
MED annual earnings per share is currently -144.19% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-97.91%
MED annual earnings per share is down -97.91% year-on-year

Annual EPS Sector Rank

47.38%
MED annual earnings per share is higher than 47.38% of companies in Consumer Cyclical sector

ROA & ROE

Annual ROA

0.70%
MED annual return on assets is 0.70%

Annual ROE

1.02%
MED annual return on equity is 1.02%

EBIT & EBITDA

Annual EBIT

$2.88 M
MED annual earnings before interest & taxes is $2.88 million

Annual EBITDA

$15.59 M
MED annual EBITDA is $15.59 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

80.39
MED price to earnings ratio is 80.39

PE Ratio Sector Rank

93.53%
MED price to earnings ratio is higher than 93.53% of companies in Consumer Cyclical sector

PB Ratio

PB Ratio

0.75
MED price to book ratio is 0.75

PB Ratio Sector Rank

33.28%
MED price to book ratio is higher than 33.28% of companies in Consumer Cyclical sector

PS Ratio

PS Ratio

0.26
MED price to sales ratio is 0.26

PS Ratio Sector Rank

20.79%
MED price to sales ratio is higher than 20.79% of companies in Consumer Cyclical sector

Enterprise value

Enterprise Value

$83.47 M
MED enterprise value is $83.47 million

Enterprise Value Sector Rank

18.97%
MED enterprise value is higher than 18.97% of companies in Consumer Cyclical sector

EV/EBITDA

EV/EBITDA

5.36
MED EV/EBITDA is 5.36

EV/EBITDA Sector Rank

31.64%
MED EV/EBITDA is higher than 31.64% of companies in Consumer Cyclical sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.34
MED annual current ratio is 3.34

Annual Quick Ratio

2.68
MED annual quick ratio is 2.68

Leverage

Annual Debt To Equity

0.00
MED annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
MED annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

7
MED piotroski f-score is 7

Altman Z-Score

4.94
MED altman z-score is 4.94

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$284.21 M
MED annual total assets is $284.21 million

Annual Non Current Assets

$69.81 M
MED annual long term assets is $69.81 million

Annual Current Assets

$214.40 M
MED annual total current assets is $214.40 million

Annual Cash & Cash Equivalents

$90.93 M
MED annual cash & cash equivalents is $90.93 million

Equity

Annual Book Value

$210.11 M
MED annual book value is $210.11 million

Annual Working Capital

$150.24 M
MED annual working capital is $150.24 million

Liabilities

Annual Total Liabilities

$74.10 M
MED annual total liabilities is $74.10 million

Annual Total Long Term Liabilities

$9.94 M
MED annual total long term liabilities is $9.94 million

Annual Current Liabilities

$64.16 M
MED annual total current liabilities is $64.16 million

Annual Accounts Payable

$23.05 M
MED annual accounts payable is $23.05 million

Debt

Annual Total Debt

$16.13 M
MED annual total debt is $16.13 million

Annual Total Debt 1-Year Change

-26.74%
MED annual total debt is down -26.74% year-on-year

Annual Long Term Debt

$9.94 M
MED annual long term debt is $9.94 million

Annual Short Term Debt

$6.18 M
MED annual short term debt is $6.18 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$599.59 M
MED annual total expenses is $599.59 million

Annual Operating Expenses

$441.75 M
MED annual total operating expenses is $441.75 million

Annual Cost Of Goods Sold

$157.84 M
MED annual cost of goods sold is $157.84 million

Annual SGA

$441.75 M
MED annual SGA is $441.75 million

Annual D&A

$12.71 M
MED annual depreciation & amortization is $12.71 million

Annual Interest Expense

-
MED annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$24.48 M
MED annual cash flow from operations is $24.48 million

Annual CFO 1-Year Change

-83.42%
MED annual cash flow from operations is down -83.42% year-on-year

Annual CFI

-$26.52 M
MED annual cash flow from investing activities is -$26.52 million

Annual CFI 1-Year Change

+56.56%
MED annual cash flow from investing activities is up +56.56% year-on-year

Annual CFF

-$1.51 M
MED annual cash flow from financing activities is -$1.51 million

Annual CFF 1-Year Change

+98.1%
MED annual cash flow from financing activities is up +98.1% year-on-year

Free CashFlow

Annual FCF

$17.02 M
MED annual free cash flow is $17.02 million

Annual FCF 1-Year Change

-87.94%
MED annual free cash flow is down -87.94% year-on-year

CAPEX

Annual CAPEX

$7.45 M
MED annual capital expenditures is $7.45 million

Annual CAPEX 1-Year Change

+14.98%
MED annual capital expenditures is up +14.98% year-on-year

Institutional Ownership

Similar stocks

NEGG logo
Newegg Commerce (NEGG)
LAKE logo
Lakeland Industries (LAKE)
KEQU logo
Kewaunee Scientific (KEQU)
INVZ logo
Innoviz Technologies (INVZ)
AKA logo
aka Brands Holding (AKA)
ELA logo
Envela (ELA)
QRTEA logo
Qurate Retail (QRTEA)
RMBL logo
RumbleON (RMBL)
DIBS logo
1stdibs (DIBS)

FAQ

  • What is the ticker symbol for Medifast?
  • Does Medifast pay dividends?
  • What sector is Medifast in?
  • What industry is Medifast in?
  • What country is Medifast based in?
  • When did Medifast go public?
  • Is Medifast in the S&P 500?
  • Is Medifast in the NASDAQ 100?
  • Is Medifast in the Dow Jones?
  • When was Medifast's last earnings report?
  • When does Medifast report earnings?
  • Should I buy Medifast stock now?

What is the ticker symbol for Medifast?

The ticker symbol for Medifast is NYSE:MED

Does Medifast pay dividends?

No, Medifast does not pay dividends

What sector is Medifast in?

Medifast is in the Consumer Cyclical sector

What industry is Medifast in?

Medifast is in the Personal Services industry

What country is Medifast based in?

Medifast is headquartered in United States

When did Medifast go public?

Medifast's initial public offering (IPO) was on December 30, 1993

Is Medifast in the S&P 500?

No, Medifast is not included in the S&P 500 index

Is Medifast in the NASDAQ 100?

No, Medifast is not included in the NASDAQ 100 index

Is Medifast in the Dow Jones?

No, Medifast is not included in the Dow Jones index

When was Medifast's last earnings report?

Medifast's most recent earnings report was on Feb 18, 2025

When does Medifast report earnings?

The next expected earnings date for Medifast is Apr 29, 2025

Should I buy Medifast stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions